Investigator Initiated Research Study AgreementInvestigator Initiated Research Study Agreement • April 23rd, 2013 • Cyto Wave Technologies Inc. • Electromedical & electrotherapeutic apparatus • Arkansas
This Investigator Initiated Study Agreement (the “Agreement”) sets forth the understanding between Cyto Wave Technolocies, Inc., a medical technology company located in 201 Spear Street, Suite 1100, San Francisco, CA 94105 (“CytoWave”) and The Board of Trustees of the University of Arkansas acting for and on behalf of the University of Arkansas for Medical Sciences (“Sponsor-Institute”) on behalf of its employee, Laura Hutchins, M.D. and Vladimir Zharov, Ph.D. (“Sponsor-Investigator”) concerning the Investigator Initiated Research Plan entitled: “Optimization Of An Experimental Prototype For Photoacoustic Detection Of Circulating Melanoma Cells And Clinical Trials In Humans” (“Research Plan”) and the Sponsor-Investigator’s clinical study protocol (the “Study”) entitled “In Vivo Real-Time Detection of Circulating Melanoma Cells”, Protocol #133965 (the “Protocol”), collectively referred herein as the “Research Project”.
